Please login to the form below

Not currently logged in

Golin appoints new group managing director

Ondine Whittington now group managing director of Golin and Virgo Health

Public relations agency Golin has appointed Ondine Whittington (pictured above) to the role of group managing director, of both Golin and Virgo Health London.

As group managing director of both Golin and Virgo, Whittington will report directly to Matt Neale, Golin’s chief executive officer.

Prior to taking on the group managing director role, Whittington worked as managing director of Virgo Health – a healthcare communications agency acquired by Golin in 2014.

While working as managing director of Virgo for the past four years, she oversaw one of the most successful years of growth in the agency’s history and the agency’s move from Richmond to Golin’s offices in London.Matt Neale

“During her time at Virgo Health, Ondine has demonstrated an incredible ability to drive growth, build client relationships, collaborate and assemble integrated teams,” said Neale (pictured right).

“Most importantly, she knows how to build and motivate high-performing teams balanced with a truly inclusive and supportive working culture,” he added.

Commenting on her new role, Whittington said: “While both the Virgo and Golin brands will remain distinct entities, the new Group MD role will allow me to unlock the collective strength of our exciting proposition and brilliant people; while creating efficiencies and value for clients.”

Article by
Lucy Parsons

11th March 2020

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...